Abstract. 7, , a member of the flavonoid family, has received considerable attention as a selective tyrosine kinase receptor B agonist. Several studies have indicated that 7,8-DHF has neurotrophic and antioxidant activities. However, little is known about the cellular and molecular mechanisms underlying the anti-inflammatory activity of 7,8-DHF. Therefore, we investigated whether 7,8-DHF affects the expression of inflammatory mediators in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Our results indicated that 7,8-DHF significantly attenuated secretion of LPS-induced inflammatory mediators nitric oxide (NO), prostaglandin E 2 (PGE 2 ) and interleukin-1β (IL-1β) in RAW264.7 cells. Additionally, LPS-induced expression of inducible NO synthase (iNOS), cyclooxygenase (COX)-2 and IL-1β was decreased by pre-treatment with 7,8-DHF. Our results also showed that 7,8-DHF reduces LPS-induced nuclear factor-κB (NF-κB) activity via the suppression of the nuclear translocation of NF-κB p65 and the degradation of inhibitor κB (lκB). In addition, 7,8-DHF inhibited the phosphorylation of mitogen-activated protein kinases (MAPKs) such as extracellular-signal-related kinase (ERK), p38, and c-Jun N-terminal kinase (JNK). These results suggest that the anti-inflammatory property of 7,8-DHF is related to the downregulation of iNOS, COX-2 and IL-1β, due to NF-κB inhibition as well as to the negative regulation of MAPK activation in RAW264.7 cells. Thus, 7,8-DHF may be a novel therapeutic agent for the prevention of various inflammatory diseases.
Introduction
Inflammation, a physiological response to infection or injury, plays a critical role in health and disease. Inflammation is a delicate mechanism composed of cellular immunity and biochemical mediators, mediated by activated inflammatory and immune cells including macrophages. In response to infection or injury, macrophages readily become activated and secrete neurotoxic and pro-inflammatory mediators, including nitric oxide (NO), prostaglandin E 2 (PGE 2 ), reactive oxygen species (ROS), and pro-inflammatory cytokines, such as interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) (1) (2) (3) . Excessive NO production during inflammation is linked to tissue damage and organ dysfunction due to the massive expression of inducible NO synthase (iNOS) expression (4, 5) . Cyclooxygenases (COXs), in the prostaglandin biosynthesis pathway, are key enzymes that catalyze the conversion of arachidonic acid to PGE 2 . It is generally accepted that PGE 2 is produced by COX-2 at sites of inflammation, and that COX-1, another constitutive isoform, is relevant in the production of prostaglandins that regulate normal cellular processes (6) . NO also acts as a modulator of COX-2 activity and directly affects its enzymatic activity (7) . In addition, IL-1β is a potential inflammatory cytokine involved in the induction of innate immune responses by macrophages and in stimulating secretion of other inflammatory cytokines (8, 9) . Thus, the regulation of macrophage activation and downregulation of pro-inflammatory mediators, including NO, PGE 2 and IL-1β in macrophages, may be safe and effective interventions for inflammatory diseases
In response to macrophage activation by an endotoxin such as lipopolysaccharide (LPS), the Toll-like receptor 4 (TLR4)-myeloid differentiation factor (MyD88) pathway
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by downregulating the NF-κB and MAPK signaling pathways in lipopolysaccharide-treated RAW264.7 cells induces rapid phosphorylation of mitogen-activated protein kinases (MAPKs) and inhibitor κB (IκB) kinase (IKK) through activation of transforming growth factor-β-activated kinase 1 (TAK1), eventually contributing to the activation of nuclear factor κB (NF-κB) and activator protein-1 (AP-1) (10, 11) . The transcription factor NF-κB is activated through the phosphorylation and subsequent degradation of IκB by IKK, and plays a central role in the onset of inflammation by increasing the level of inflammatory mediators (10, 12, 13) . The gene expression of these inflammatory mediators is also regulated by AP-1, another transcription factor that is crucial for inflammation. AP-1 is mainly activated through MAPKs such as extracellular-signal-related kinase (ERK), p38 and c-Jun N-terminal kinase (JNK) (14) (15) (16) . Therefore, many putative anti-inflammatory therapies are based on the blocking of NF-κB and MAPK activity.
Flavonoids are a diverse group of natural plant products synthesized from phenylpropanoid and acetate-derived precursors that are present in high concentrations in fruits and vegetables (17, 18) . They are becoming an important source of novel agents with pharmaceutical potential and have attracted a great deal of attention for their role in the prevention of chronic diseases (19) (20) (21) . Flavonoids display a remarkable spectrum of biological properties, including anti-allergic, antiinflammatory, antioxidant, and anticancer effects, as well as immunomodulation and modulation of enzymatic activities (22) (23) (24) (25) (26) . Among them, 7,8-dihydroxyflavone (7,8-DHF) is a recently identified tyrosine kinase receptor B (TrkB) agonist that can cross the blood-brain barrier (18, 27, 28) . Recently, 7,8-DHF has been reported to have neurotrophic activities in various neurological diseases, such as stroke and Parkinson's disease (27) . Although several studies on the antioxidant effects of 7,8-DHF have been carried out (18, 29, 30) , the molecular mechanisms underlying its anti-inflammatory effects have yet to be reported.
In this study, we investigated the inhibitory effects of 7,8-DHF and the manner in which it induces anti-inflammatory mechanisms in lipopolysaccharide (LPS)-stimulated inflammatory mediator production in RAW264.7 cells. This is the first study reporting that 7,8-DHF significantly attenuates the levels of NO, PGE 2 and IL-1β in LPS-stimulated murine macrophage RAW264.7 cells via suppression of the NF-κB and MAPK signaling pathways.
Materials and methods
Cell culture. RAW264.7 murine macrophage cells were kindly provided by Professor Il Whan Choi of Inje University (Busan, Korea) and cultured at 37̊C in 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM, Gibco BRL, Gaithersburg, MD) supplemented with 10% fetal bovine serum (FBS), 100 U/ ml penicillin and 100 µg/ml streptomycin. The 7,8-DHF was obtained from Professor Jin Won Hyun of Jeju National University (Jeju, Korea) and dissolved in dimethyl sulfoxide (DMSO); dilutions were made in DMEM. The final concentration of DMSO in the medium was <0.0005% (vol/vol), which had no impact on cell growth. In all experiments, cells were pre-treated with the indicated concentrations of 7,8-DHF for 1 h prior to the addition of LPS (Sigma-Aldrich Chemical Co., St. Louis, MO).
Cell viability assay. Cell viability was measured based on the formation of blue formazan metabolized from colorless 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich) by mitochondrial dehydrogenases, which are active only in viable cells. RAW264.7 cells were plated into 24-well plates at a density of 2x10 5 cells/well for 24 h, and then washed. The cells incubated with various concentrations of 7,8-DHF were treated with or without 0.5 µg/ml LPS for 24 h, and then incubated in 0.5 mg/ml MTT solution. Three hours later, the supernatant was removed and formation of formazan was measured at 540 nm using a microplate reader (31) .
Measurement of NO production. Concentrations of NO in culture supernatants were determined as nitrite, a major stable product of NO, using the Griess reagent (Sigma-Aldrich). After cells (5x10 5 cells/ml) were stimulated in 24-well plates for 24 h, 100 µl of each cultured medium was mixed with the same volume of the Griess reagent [1% sulfanilamide/0.1% N-(1-naphthyl)-ethylenediamine dihydrochloride/2.5% H 3 PO 4 ). Nitrite levels were determined using an ELISA plate reader at 540 nm, and nitrite concentrations were calculated by reference to a standard curve generated by known concentrations of sodium nitrite (32) .
Measurement of PGE 2 production. RAW264.7 cells were incubated with 7,8-DHF in either the presence or absence of LPS (0.5 µg/ml) for 24 h. Following the manufacturer's instructions, a volume of 100 µl of culture-medium supernatant was collected to determine PGE 2 concentration by ELISA (Cayman, MI) (33) .
Reverse transcriptase-polymerase chain reaction. Total RNA was isolated using TRIzol reagent (Invitrogen, CA). Total RNA (1.0 µg) obtained from cells was primed with random hexamers to synthesize complementary DNA using M-MLV reverse transcriptase (Promega, Madison, WI), according to the manufacturer's instructions. Polymerase chain reaction (PCR) was performed for amplification of the IL-1β gene from the cDNA, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control. Conditions for the PCR reactions were 1 x (94̊C for 3 min); 35 x (94̊C for 45 sec; 58̊C for 45 sec; and 72̊C for 1 min); and 1 x (72̊C for 10 min). Amplification products obtained by PCR were electrophoretically separated on 1% agarose gel and visualized by ethidium bromide (EtBr) staining.
Protein extraction and western blot analysis.
For western blot analysis, cells were harvested and washed twice in phosphate-buffered saline (PBS) at 4̊C. Total cells lysates were lysed in lysis buffer [40 mM Tris (pH 8.0), 120 mM, NaCl, 0.5% NP-40, 0.1 mM sodium orthovanadate, 2 µg/ml aprotinin, 2 µg/ml leupeptin, and 100 µg/ml phenymethylsulfonyl fluoride]. The supernatants were collected and protein concentrations were then measured with protein assay reagents (Pierce Biotechnology, Rockford, IL). Equal amounts of protein extracts were denatured by boiling at 95̊C for 5 min in sample buffer (0.5 M Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 0.1% bromophenol blue, 10% β-mercaptoethanol) in a ratio of 1:1, subjected to 8-10% sodium dodecyl sulfate (SDS)-polyacrylamide gels, and transferred to polyvinylidene difluoride membranes (Schleicher & Schuell, Keene, NH) by electroblotting. The membranes were blocked with 5% non-fat dry milk in PBS with Tween-20 buffer (PBS-T) (20 mM Tris, 100 mM NaCl, pH 7.5, and 0.1% Tween-20) for 1 h at room temperature. Membranes were then incubated overnight at 4̊C with the primary antibodies, probed with enzyme-linked secondary antibodies, and visualized using an enhanced chemiluminescence (ECL) kit (Amersham, Arlington Heights, IL), according to the manufacturer's instructions. In a parallel experiment, nuclear proteins were prepared using the NE-PER nuclear extraction reagent (Pierce Biotechnology), according to the manufacturer's protocol.
Enzyme immunosolvent assay (ELISA).
The levels of IL-1β were measured by the ELISA kit (R&D Systems, Minneapolis, MN), according to the manufacturer's instructions. Briefly, RAW264.7 cells (5x10 5 cells/ml) were plated in 24-well plates and pre-treated with the indicated concentrations of 7,8-DHF for 1 h before treatment of 0.5 µg/ml LPS for 24 h. One hundred microliters of culture-medium supernatants were collected for determination of IL-1β concentration by ELISA (34) .
Statistical analyses. Data values represent the means ± SD Statistical significance was determined using an analysis of variance, followed by the Student's t-test. A value of p<0.05 was considered to indicate a statistically significant difference.
Results

7,8-DHF attenuates NO production via suppression of iNOS expression.
To investigate the effects of 7,8-DHF on NO production, cell culture supernatants were collected, and the levels of nitrite were measured with the Griess reagent. Stimulation with LPS alone resulted in an approximate 10-fold increase in NO production compared with the untreated control; however, 7,8-DHF resulted in a concentration-dependent decrease in NO production. In particular, pre-treatment for 1 h with 30 µM and 50 µM 7,8-DHF greatly decreased NO production by more than 60 and 46%, respectively, compared with LPS alone (Fig. 1A) . Next, we evaluated whether 7,8-DHF treatment decreases protein expression of iNOS in LPS-stimulated RAW264.7 cells using western blot analysis. Stimulation with LPS alone significantly induced expression of iNOS protein; however, 7,8-DHF markedly inhibited expression of the LPS-induced iNOS protein (Fig. 1B) . The data suggest that 7,8-DHF inhibits LPS-induced NO production via suppression of iNOS expression. 2 production via suppression of COX-2 expression. As it is well known that PGE 2 is involved in the production of pro-inflammatory agents, we examined the effects of 7,8-DHF on PGE 2 secretion in LPS-stimulated RAW264.7 cells. As shown in Fig. 2A , stimulation with LPS alone significantly increased secretion of PGE 2 >4.5-fold compared with the control, 24 h treatment, the cells were lysed and the cellular proteins (50 µg) were separated by electrophoresis on SDS-polyacrylamide gel and transferred to nitrocellulose membranes. Membranes were probed with anti-COX-2 antibody and the proteins were visualized using an ECL detection system. Actin was used as an internal control. while 7,8-DHF reversed the increased PGE 2 production in a concentration-dependent manner. Pre-treatment with 50 µM 7,8-DHF decreased LPS-induced PGE 2 production to approximately control levels. Consistent with these data, treatment of cells with LPS alone significantly increased expression of the COX-2 protein (Fig. 2B) , which is the ratelimiting enzyme of PGE 2 production. However, 7,8-DHF concentration-dependently inhibited this increase in LPS-stimulated RAW264.7 cells. Taken together, these data indicate that 7,8-DHF significantly suppresses the release of PGE 2 in LPS-stimulated RAW264.7 cells via suppression of the COX-2 expression.
7,8-DHF decreases LPS-induced PGE
7,8-DHF suppresses IL-1β secretion via suppression of the IL-1β gene expression.
IL-1β is one of the major pro-inflammatory cytokines induced by LPS. Therefore, we assessed whether 7,8-DHF modulates secretion of IL-1β in LPS-stimulated RAW264.7 cells. As indicated in Fig. 3A , IL-1β secretion was significantly increased by LPS stimulation alone at 24 h; however, pre-treatment with 7,8-DHF resulted in a decrease in the release of IL-1β in a concentration-dependent manner (Fig. 3A) . To investigate the effect of 7,8-DHF pre-treatment on the expression of IL-1β, reverse transcription-PCR analysis was performed. Consistent with the attenuation of IL-1β secretion, 7,8-DHF reduced the expression of IL-1β mRNA in LPS-stimulated RAW264.7 cells compared with LPS alone (Fig. 3B) . These results suggest that 7,8-DHF suppresses LPS-stimulated IL-1β release through attenuation of the IL-1β mRNA expression.
7,8-DHF blocks LPS-induced NF-κB activation.
Since NF-κB is a critical transcriptional factor that regulates LPS-induced expression of genes for pro-inflammatory mediators, including iNOS, COX-2 and IL-1β, we investigated whether 7,8-DHF modulates the activation of NF-κB in RAW264.7 cells in response to LPS. To verify the regulation of NF-κB activity, we examined the effect of 7,8-DHF on LPS-induced nuclear translocation of the NF-κB p65 subunit and IκB-α degradation by western blot analysis. Our immunoblotting data indicated that stimulation of cells with LPS induced the degradation of IκBα, and the translocation of the NF-κB p65 subunit from the cytosol to the nucleus (Fig. 4A) . However, LPS-induced IκB degradation was inhibited after 30 min of exposure to 7,8-DHF. Additionally, 7,8-DHF inhibited nuclear translocation of the NF-κB p65 protein (Fig. 4B) . Taken together, our findings demonstrate that 7,8-DHF inhibits the NF-κB signaling pathway via suppression of the nuclear translocation of NF-κB and IκB-α degradation.
7,8-DHF reduces LPS-induced phosphorylation of MAPKs.
To further investigate other intracellular mechanisms responsible for the inhibitory effect of 7,8-DHF on inflammatory mediators, we examined the effect of 7,8-DHF on MAPK signaling pathways. As shown in Fig. 5 , stimulation of RAW264.7 cells with LPS led to rapid activation of p38, ERK and JNK with the peak levels of each phospho-MAPK occurring 15 to 60 min after the addition of LPS. However, 7,8-DHF pre-treatment significantly inhibited phosphorylation of these MAPKs in LPS-stimulated RAW264.7 cells. These results suggest that the activation of MAPKs may be involved in the inhibitory effect of 7,8-DHF on LPS-induced pro-inflammatory mediators in RAW264.7 cells. 
7,8-DHF does not affect cell viability.
To assess whether or not the anti-inflammatory effects of 7,8-DHF in RAW264.7 cells were due to its cytotoxic effects, an MTT assay was performed 24 h after treatment with the indicated concentrations of 7,8-DHF in the presence or absence of LPS. Results from the MTT assay showed that the concentrations (5-50 µM) used for inhibition of NO, PGE 2 and IL-1β production did not affect cell viability (Fig. 6 ). In addition, LPS (0.5 µg/ml) alone was not cytotoxic and vehicle control (0.0005% DMSO) also had no impact on cell viability. The results confirmed that inhibition of NO, PGE 2 and IL-1β production in LPS-stimulated RAW264.7 cells was not due to a cytotoxic action of 7,8-DHF.
Discussion
In the present study, we demonstrated that 7,8-DHF in LPS-activated RAW264.7 cells inhibits LPS-induced production of key pro-inflammatory mediators, such as NO, PGE 2 and IL-1β. These effects were accompanied by downregulation of the NF-κB activity, and inactivation of the MAPK signaling pathway without cytotoxicity.
Inflammation is the first response of the immune system to infection or irritation. Pro-inflammatory mediators such as iNOS, COX-2 and IL-1β play a crucial role in immune responses by increasing the levels of NO, PGE 2 , and IL-1β, which result in many of the damaging effects observed in inflammation-related diseases (1) (2) (3) . Although the production of pro-inflammatory mediators is important to promote anti-bacterial, anti-viral, and anticancer response, excessive production is involved in the initiation and process of severe inflammation (16, 35, 36) . Thus, inhibitors of these inflammatory mediators have been considered as candidates for the development of drugs and functional foods to attenuate inflammatory diseases. In this study, as a component of our ongoing screening for new biologically active compounds from natural compounds, we tested the effects of 7,8-DHF, a member of the flavonoid family, on the production of inflammatory mediators in LPS-stimulated RAW264.7 macrophages. We found that 7,8-DHF significantly decreased secretion levels of LPS-induced NO, PGE 2 and IL-1β, which was associated with the suppression of iNOS, COX-2 and IL-1β expression, respectively.
The transcription factor NF-κB is a primary regulator of genes that tightly regulates the expression of many genes involved in severe inflammatory diseases (10, 11) . The blockade of NF-κB transcriptional activity is also known to suppress expression of pro-inflammatory mediators including iNOS, COX-2, and IL-1β (37) (38) (39) . Therefore, downregulation of NF-κB activity is a useful strategy to regulate inflammatory diseases. Previous reports have indicated that stimulation with LPS induces IκB phosphorylation and proteosomal degradation in cytosol, which releases NF-κB subunits from IκB allowing their nuclear translocation and subsequent binding to their specific promoter regions. This leads to the activation of several signal transduction pathways in macrophages that trigger the secretion of inflammatory mediators (10, 12, 13) . Thus, we evaluated the effect of 7,8-DHF on LPS-induced NF-κB activation to confirm whether the inhibitory effects of 7,8-DHF on the production of NO, PGE 2 and IL-1β were regulated by the NF-κB signaling pathway. We found that the translocation of NF-κB factor p65, which is normally translocated from the cytoplasm to the nucleus after exposure to LPS, was strongly inhibited by 7,8-DHF through blockage of LPS-induced IκB-α degradation. This result suggests that the inhibitory effects of 7,8-DHF on the production of inflammatory mediators are at least partially mediated by the suppression of the NF-κB signaling pathway.
Involvement of various intracellular signaling pathways, such as MAPKs, in inflammatory mediator induction has been reported (14-16). LPS is also known to activate a series Total protein was subjected to 10% SDS-polyacrylamide gels, followed by western blotting using the indicated antibodies. Proteins were visualized using an ECL detection system.
of MAPKs, such as ERK, p38 and JNK after engagement of cluster of differentiation 14/Toll-like receptor 4 (CD14/ TLR) receptors on the cell surface in macrophages, which play important roles in LPS-induced cellular responses (40, 41) . Therefore, subsequent experiments were performed to determine the effects of 7,8-DHF on the LPS-induced phosphorylation of MAPKs in RAW264.7 cells. As shown in our results, LPS induced rapid phosphorylation of ERK, JNK and p38 in RAW264.7 cells. However, 7,8-DHF markedly inhibited LPS-induced phosphorylation of these kinases. These results indicate that the effects of 7,8-DHF on the production of inflammatory mediators could occur through the blocking of the MAPK signaling pathway.
In conclusion, the results presented in this study, demonstrate that 7,8-DHF inhibits LPS-induced NO, PGE 2 and IL-1β production by suppressing iNOS, COX-2 and IL-1β expression in RAW264.7 macrophage cells. The inhibitory action of 7,8-DHF was mediated by the prevention of NF-κB activation and by the inhibition of IκB-degradation, which is accompanied by the blocking of the MAPK pathways. As a result of the findings presented in this report, we suggest that 7,8-DHF may provide an effective treatment for numerous inflammatory diseases.
